Press Releases

As The American Journal of Managed Care marks its 20th year of publication, the editors invited Margaret O'Kane, the founding and current president of the National Committee on Quality Assurance, to address today's retail environment for healthcare consumers. In 2015, NCQA marks its 25th year of improving healthcare quality through measurement, transparency, and accountability.

A year after Sovaldi's $1,000-a-pill price tag set off a national discussion, new entrants in the market to cure the hepatitis C virus have allowed pharmacy benefit managers to bring down its cost for health plans. Experts convened by The American Journal of Managed Care said this should expand who gets treatment, but they also say this won't be last of the high-cost specialty drugs.

The Patient Access Network or PAN Foundation formed more than 10 years ago, partially in response to the Medicare Part D benefit. It helps patients meet cost-sharing requirements across dozens of diseases, including 25 in oncology; Evidence-Based Oncology, a publication of The American Journal of Managed Care, invited PAN Foundation President and CEO Dan Klein to discuss its role in immuno-oncology.

Suzanne F. Delbanco, PhD, MPH, executive director of Catalyst for Payment Reform, will be the keynote speaker at the spring meeting of the ACO and Emerging Healthcare Delivery Coalition, to be held April 30 and May 1, 2015, in San Diego, California. The ACO Coalition, an initiative of The American Journal of Managed Care, brings together stakeholders from across the healthcare spectrum interested in sharing best practices relative to the changing delivery and payment models.

Evidence-Based Oncology, an indexed publication of The American Journal of Managed Care, devotes its current issue to immuno-oncology and the interests of many stakeholders. In a commentary that draws on 30 years of waiting on the promise of immuno-oncology, Bruce Feinberg, DO, outlines the key issues facing payers, oncologists, policymakers and patients themselves.

Jeffrey S. McCullough, PhD, who writes frequently on the intersection of health information technology (IT) and quality, will serve as guest editor for the 5th annual special issue of The American Journal of Managed Care devoted to research and commentary on health IT. Dr McCullough's services come during AJMC's celebration of its 20th year as the leading peer-reviewed journal covering healthcare delivery systems.

Sessions on clinical, behavioral and technological advances will cover all aspects of diabetes care April 16-17 in Boston, when The American Journal of Managed Care and Joslin Diabetes Center will partner to present Patient-Centered Diabetes Care 2015. The program and faculty of this conference, to be held at the Renaissance Waterfront Boston, are not to be missed.

The American Journal of Managed Care arrived in 1995, in the aftermath of the last major effort to remake the US healthcare system, and quickly became the most important forum of its type. Today, with the country implementing the Affordable Care Act, Editors-in-Chief A. Mark Fendrick, MD, and Michael Chernew, PhD, examine the impact of the journal's contributions to healthcare delivery transformation.

The American Journal of Managed Care arrived in 1995, in the aftermath of the last major effort to remake the US healthcare system, and quickly became the most important forum of its type. Today, with the country implementing the Affordable Care Act, Editors-in-Chief A. Mark Fendrick, MD, and Michael Chernew, PhD, examine the impact of the journal's contributions to healthcare delivery transformation.

The leading peer-reviewed journal in managed care and the world leader in diabetes research and clinical care will present the conference at the Renaissance Boston Waterfront April 16-17, 2015. Faculty presentations and panel discussions will cover clinical, behavioral and technological aspects of care for persons with type 1 and type 2 diabetes mellitus.

The leading peer-reviewed journal in managed care and the world leader in diabetes research and clinical care will present the conference at the Renaissance Boston Waterfront April 16-17, 2015. Faculty presentations and panel discussions will cover clinical, behavioral and technological aspects of care for persons with type 1 and type 2 diabetes mellitus.

Through the partnership, PQA will contribute a regular column, Medication Quality Matters, that will help readers understand new performance measures.

Through the partnership, PQA will contribute a regular column, Medication Quality Matters, that will help readers understand new performance measures.

The main barrier to widespread use of telehealth isn't technology or consumer acceptance; it's figuring out how to pay for it. Authors writing for The American Journal of Managed Care and The American Journal of Accountable Care discuss why today's payment models for accountable care organizations are a better fit for telehealth, and why regulatory changes make sense.

The Affordable Care Act and a federal parity law have already helped persons with mental illness get access to proper care. But a leading advocate, a medical director for Cigna, and a psychiatrist who has studied innovative care delivery models say more can be done to improve screening, to ensure the correct diagnosis, and to provide better access to services.

Accountable care organizations (ACOs) are still a new creature in the world of managed care, and not all are alike. As the authors of a new comparative analysis in The American Journal of Managed Care outline, Medicare contracts dominate the ACO landscape, with only half of these entities having a contract with a private payer.

How do ACOs reach the point of delivering both savings and better care? The recent online session of the ACO and Emerging Healthcare Delivery Coalition, sponsored by The American Journal of Managed Care, covered how ACOs evolve, how that process applies to oncology care, and how managed care can benefit from a better model for mental health delivery.

What makes a cancer therapy effective may be in the eye of the stakeholder, even though everyone involved in healthcare decisions relies on evidence-based information. Evidence-Based Oncology, a publication of The American Journal of Managed Care, this month publishes a condensed version of the discussion among payers on how to improve collection and use of collection of data to make better evidence-based decisions in oncology.

The call for value-based care is propelled by the shortage of family physicians and the disparity connection between the time it takes to care for the sickest patients and what Medicare and Medicaid pay. A study in this month's issue of The American Journal of Managed Care tracks just how bad things are, by looking at a normal day in a family practice.

A commentary in this month's issue of The American Journal of Managed Care explores whether allowing generic versions of medications to look like branded equivalents would be better for consumers and improve adherence.

The toughest topics in cancer care will be on tap November 13-14, 2014, in Baltimore, Maryland, when AJMCLive presents Patient-Centered Oncology Care. If you've followed the discussion among pharmaceutical leaders, oncologists, and payers over access to care, you'll want to join stakeholders to discuss how to ensure patients get what they need while controlling costs.

The Centers for Medicare and Medicaid Services wants hospitals to find ways to keep patients from returning to the hospital, and the agency has created rewards and punishments in pursuit of this goal. A study in The American Journal of Managed Care is just one of a pair of recent clinical trials that finds readmissions may be beyond some hospitals' control, and policymakers might need to rethink their approach.

With a shortage of primary care physicians and the costs that come with a trip to the emergency room, can retail clinics fill the gap? A study published today in The American Journal of Managed Care finds they can, offering care that is just as good or better for common ailments like ear infections or strep throat.

Immuno-oncology, in which the patient's own immune system is engaged to fight cancer, has shown potential but also presents challenges, including the cost of treatment. Last month, The American Journal of Managed Care convened an expert panel to discuss the value of current therapies and how payers make policy calls

Fictional teens with cancer may be suddenly popular in film and TV, but they are hard to find in the one place where they are most needed: in clinical trials to find drugs to save their lives. A story in the new issue of Evidence-Based Oncology, a publication of The American Journal of Managed Care, examines this problem.

Both Medicare and commercial insurers have raised the bar for molecular diagnostic companies, requiring them to show clinical utility to receive reimbursement for cellular tests designed to guide treatment in cancer, rheumatoid arthritis, and other diseases. An important new article in The American Journal of Managed Care reviews cases from a top Medicare contractor and outlines how to build the evidence to meet today's standards.

The accountable care organization, or ACO, can be a mechanism for employers to achieve healthcare savings, according to a just-published article in The American Journal of Accountable Care, the publication of The American Journal of Managed Care dedicated to healthcare reform.

The American Journal of Managed Care brings the next meeting of its ACO and Emerging Healthcare Delivery Coalition to the Miami Marriott Biscayne Bay October 16-17, 2014, where participants can learn and share best practices in an effort to improve overall patient outcomes.

For most of the spring, news on the Affordable Care Act was all about the numbers, and to much surprise enrollment surpassed the magical 7 million mark. Now, Patricia Salber, MD, and Christobel Selecky report in The American Journal of Accountable Care what having coverage means, whether it makes a difference, and what are the unanswered questions.

Putting various branded drugs in "non-preferred" tiers and charging higher copays for them has been used for a number of years to steer consumers to use less costly medicines by giving them "skin in the game." But authors writing for The American Journal of Managed Care are alarmed by the policies of some insurers that now have designated entire classes of widely used generic drugs "non-preferred," leaving many patients without any low-cost treatment options for their diseases.